ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1,3,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
1,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2,2,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
2,3,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
3,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
4,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
5,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5,2,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
6,1,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
7,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
7,2,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
8,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
9,1,Renal tubular dysfunction,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
10,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
12,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
13,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
14,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
14,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
14,3,Headache,Headaches NEC,Headaches,Nerv,N
14,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
14,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
14,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
14,7,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
15,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
16,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
16,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
17,1,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
18,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
19,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
20,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
21,1,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
21,2,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
22,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
22,2,Parotitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
23,1,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
23,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
24,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,Y
24,2,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
25,1,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
26,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
27,1,Parotitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
28,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
28,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
29,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
30,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
30,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
31,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
31,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
31,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
31,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
32,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
32,2,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
32,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
32,4,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
32,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
33,1,Demyelinating polyneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
33,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
34,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
34,2,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
35,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
36,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
37,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
37,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
37,3,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
38,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,Y
38,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
39,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
39,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
40,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
41,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
41,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
41,3,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
41,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
41,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
41,6,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
42,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
42,2,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
42,3,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
42,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
43,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,Y
44,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
44,2,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
45,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
46,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
46,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
46,3,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
46,4,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
46,5,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
46,6,Mitochondrial cytopathy,Cell metabolism disorders NEC,Metabolism disorders NEC,Metab,Y
46,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
46,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
47,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
48,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
48,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
48,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
48,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
48,5,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
48,6,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
49,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
50,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
50,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
51,1,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
51,2,Pancreatitis haemorrhagic,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
52,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
53,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
54,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
54,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
54,3,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
54,4,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
54,5,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
54,6,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
54,7,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
54,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
55,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
56,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
56,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
56,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
56,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
57,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
57,2,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
57,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
57,4,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
57,5,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
58,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
58,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
58,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
58,4,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
59,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
60,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
61,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
62,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
62,2,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
63,1,Insulin resistance,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
63,2,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
63,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
63,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
64,1,Blood insulin increased,"Gastrointestinal, pancreatic and APUD hormone analyses",Endocrine investigations (incl sex hormones),Inv,N
64,2,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
64,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
64,4,Hypoglycaemia neonatal,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
64,5,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
64,6,Small for dates baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
65,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
65,2,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
66,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,Y
66,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
67,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
68,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
68,2,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
68,3,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
68,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
68,5,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
68,6,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
68,7,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
68,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
68,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
69,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
70,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
70,2,Neonatal respiratory distress syndrome,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
70,3,Sepsis neonatal,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
71,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
71,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,Y
71,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
71,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
72,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
73,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
74,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,Y
75,1,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,Y
76,1,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
77,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
78,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
79,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
79,2,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
79,3,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
79,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
80,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
80,2,Amniotic cavity infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
80,3,Premature rupture of membranes,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
81,1,Premature separation of placenta,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
82,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
82,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
83,1,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
83,2,Optic atrophy,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
84,1,Amniotic cavity infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
84,2,Headache,Headaches NEC,Headaches,Nerv,N
84,3,Induced labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
84,4,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
84,5,Premature rupture of membranes,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
84,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
85,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
85,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
86,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,Y
87,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
87,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
88,1,Fanconi syndrome acquired,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
88,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
89,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
89,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
89,3,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
89,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
89,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
90,1,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
91,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
91,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
91,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
91,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
91,5,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
91,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
91,7,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
91,8,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
92,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
93,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
94,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
94,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
94,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
94,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
94,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
95,1,HELLP syndrome,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
95,2,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
96,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
97,1,HELLP syndrome,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
97,2,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
98,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
98,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
98,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
98,4,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
98,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
98,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
98,7,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
98,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
99,1,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
100,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
100,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
100,3,Intention tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
101,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
102,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
102,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
102,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
103,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
104,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
105,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
106,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
106,2,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
106,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
106,4,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
107,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
108,1,Hyperuricaemia,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
109,1,Blood uric acid increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
110,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
111,1,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
111,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
112,1,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
113,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
114,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
114,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
114,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
115,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
115,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
116,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
116,2,Salivary gland enlargement,Salivary gland enlargements,Salivary gland conditions,Gastr,N
117,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
118,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
118,2,Lipid metabolism disorder,Lipid metabolism and deposit disorders NEC,Lipid metabolism disorders,Metab,N
118,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
119,1,Arnold-Chiari malformation,Cerebellar disorders congenital,Neurological disorders congenital,Cong,N
119,2,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
119,3,Meningomyelocele,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
119,4,Spina bifida,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
120,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
120,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
121,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
122,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
122,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
122,3,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
122,4,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
122,5,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
122,6,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
122,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
123,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
123,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
123,3,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
124,1,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
124,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
124,3,Urinary tract disorder,Genital and urinary tract disorders NEC,Genitourinary tract disorders NEC,Renal,N
125,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
126,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
126,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
127,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
128,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
128,2,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
128,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
128,4,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
128,5,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
128,6,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
128,7,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
128,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
129,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
129,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
130,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
130,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
130,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
131,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,Y
132,1,Hydrocholecystis,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
133,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
134,1,Deafness,Hearing losses,Hearing disorders,Ear,N
134,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
135,1,Blood osmolarity increased,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
135,2,Glucose tolerance decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
136,1,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
136,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
136,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
137,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
138,1,Granulomatous liver disease,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
139,1,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
139,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
140,1,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
141,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
141,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
141,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
141,4,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
141,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
142,1,Migraine,Migraine headaches,Headaches,Nerv,N
143,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
144,1,Exomphalos,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
144,2,Pulmonary valve stenosis,Pulmonary valvular disorders,Cardiac valve disorders,Card,N
145,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
145,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
145,3,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
145,4,Lipomatosis,Lipid metabolism and deposit disorders NEC,Lipid metabolism disorders,Metab,N
146,1,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
147,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
148,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
148,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
149,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
150,1,Deafness,Hearing losses,Hearing disorders,Ear,N
150,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
151,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
151,2,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
151,3,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
151,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
152,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
152,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
152,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
153,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
154,1,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
154,2,Lipase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
154,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
154,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
154,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
155,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
156,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
157,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
157,2,Bradyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
158,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
158,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
158,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
158,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
158,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
159,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
160,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
161,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
162,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
163,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
164,1,Apolipoprotein B increased,Lipoprotein and lipid tests NEC,Lipid analyses,Inv,N
164,2,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
164,3,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
164,4,Vein disorder,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
165,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
165,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
165,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
165,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
166,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
166,2,Retinal oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
167,1,Retinal disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
168,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
169,1,Fat redistribution,Lipid metabolism and deposit disorders NEC,Lipid metabolism disorders,Metab,N
170,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
170,2,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
170,3,Cystitis ulcerative,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
170,4,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
170,5,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
170,6,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
170,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
171,1,HELLP syndrome,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
171,2,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
171,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
172,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
172,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
173,1,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
173,2,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
174,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
174,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
174,3,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
174,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
175,1,Headache,Headaches NEC,Headaches,Nerv,N
175,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
175,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
176,1,Failure to thrive,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
176,2,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
176,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
177,1,Sudden infant death syndrome,Death and sudden death,Fatal outcomes,Genrl,Y
178,1,Hyperuricaemia,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
178,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
178,3,Leukaemoid reaction,Leukocytoses NEC,White blood cell disorders,Blood,N
178,4,Reye's syndrome,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
179,1,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
179,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
179,3,Blood fibrinogen decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
179,4,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,Y
179,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
179,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
179,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
180,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
180,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
180,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
180,4,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
180,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
181,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
182,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
183,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
184,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
185,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
186,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
186,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
186,3,Headache,Headaches NEC,Headaches,Nerv,N
186,4,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
186,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
187,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
188,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
188,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
188,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
188,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
189,1,Arteriovenous malformation,Vascular anomalies congenital NEC,Cardiac and vascular disorders congenital,Cong,N
189,2,Atrial septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
189,3,Congenital pulmonary valve atresia,Cardiac valve disorders congenital,Cardiac and vascular disorders congenital,Cong,N
189,4,Congenital tricuspid valve stenosis,Cardiac valve disorders congenital,Cardiac and vascular disorders congenital,Cong,N
189,5,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
189,6,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
189,7,Heterotaxia,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
189,8,Pulmonary arteriovenous fistula,Vascular anomalies congenital NEC,Cardiac and vascular disorders congenital,Cong,N
189,9,Ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
189,10,Ventricular hypoplasia,Cardiac hypoplasias congenital,Cardiac and vascular disorders congenital,Cong,N
190,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
190,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
190,3,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
190,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
190,5,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
190,6,Headache,Headaches NEC,Headaches,Nerv,N
190,7,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
190,8,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
190,9,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
190,10,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
190,11,Mitochondrial cytopathy,Cell metabolism disorders NEC,Metabolism disorders NEC,Metab,N
190,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
190,13,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
190,14,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
191,1,Hepatitis chronic active,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
191,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
192,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,Y
193,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
193,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
194,1,Congenital central nervous system anomaly,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
194,2,Pulmonary hypoplasia,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
194,3,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
195,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
196,1,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
196,2,Foetal malformation,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
196,3,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
197,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
197,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
197,3,Hepatic fibrosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
197,4,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
197,5,Portal vein thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
197,6,Varices oesophageal,Oesophageal varices,Gastrointestinal vascular conditions,Gastr,N
198,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
199,1,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
200,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
200,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
201,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
201,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
201,3,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
201,4,Headache,Headaches NEC,Headaches,Nerv,N
201,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
201,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
201,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
202,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
202,2,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,Y
202,3,Lipids increased,Lipoprotein and lipid tests NEC,Lipid analyses,Inv,N
203,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
204,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
205,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
206,1,Foetal disorder,Foetal complications NEC,Foetal complications,Preg,N
207,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
208,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
209,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
210,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
211,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
211,2,Amniotic cavity infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
212,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
213,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
214,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
215,1,Myopathy,Myopathies,Muscle disorders,Musc,N
216,1,HELLP syndrome,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
217,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
217,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
217,3,Hypermetropia,Refractive and accommodative disorders,Vision disorders,Eye,N
217,4,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
217,5,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
217,6,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
217,7,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
218,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
218,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
219,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
220,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
221,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
222,1,Kidney malformation,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
223,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
224,1,Hepatitis B,Hepatitis virus infections,Viral infectious disorders,Infec,N
224,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
224,3,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
224,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
224,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
225,1,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
225,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
225,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
226,1,Fanconi syndrome acquired,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
226,2,Stress fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
227,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
228,1,Pancreatitis haemorrhagic,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
229,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
229,2,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
229,3,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
230,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
230,2,Blood lactate dehydrogenase,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
231,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
231,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
231,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
232,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
233,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
233,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
233,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
234,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
235,1,Focal nodular hyperplasia,Hepatobiliary neoplasms benign,Hepatic and biliary neoplasms benign,Neopl,N
235,2,Gastric varices haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
236,1,Focal nodular hyperplasia,Hepatobiliary neoplasms benign,Hepatic and biliary neoplasms benign,Neopl,N
236,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
236,3,Varices oesophageal,Oesophageal varices,Gastrointestinal vascular conditions,Gastr,N
237,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
237,2,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
237,3,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
237,4,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
238,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
238,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
238,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
238,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
238,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
238,6,Hepatorenal failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
238,7,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
238,8,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
238,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
238,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
238,11,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
239,1,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
239,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
239,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
239,4,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
239,5,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
239,6,Myopathy,Myopathies,Muscle disorders,Musc,N
239,7,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
239,8,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
239,9,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
239,10,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
239,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
240,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
241,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
242,1,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
242,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
243,1,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
243,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
243,3,Mycobacterium avium complex infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
244,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
244,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
244,3,Hepatitis B reactivation,Hepatitis virus infections,Viral infectious disorders,Infec,N
244,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
245,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
245,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,Y
246,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
246,2,Peyronie's disease,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
247,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
248,1,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
248,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,Y
248,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
249,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
250,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
251,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
252,1,Pancreatitis necrotising,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
253,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
254,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
255,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
256,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
256,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
256,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
256,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
256,5,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
256,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
257,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
257,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
258,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
258,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
258,3,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
259,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
259,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
259,3,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
259,4,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
260,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
261,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,Y
261,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
262,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
263,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
264,1,Gestational hypertension,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
264,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,Y
265,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
265,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
265,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
266,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
266,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
266,3,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
266,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
266,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
266,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
266,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
266,8,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
267,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
268,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
269,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
269,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
270,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
270,2,Gastrointestinal ulcer,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
270,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
270,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
270,5,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
270,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
271,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
272,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
272,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
272,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
273,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
273,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
273,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
274,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
275,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
275,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
276,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
277,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
277,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
277,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
278,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
278,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
278,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
278,4,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
278,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
278,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
278,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
278,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
278,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
278,10,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
278,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
279,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
280,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
281,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
281,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
282,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
283,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
284,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
284,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
284,3,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
285,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
285,2,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
285,3,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
285,4,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
286,1,Acquired immunodeficiency syndrome,Retroviral infections,Viral infectious disorders,Infec,N
286,2,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
286,3,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
286,4,Hypogonadism,Endocrine abnormalities of gonadal function NEC,Endocrine disorders of gonadal function,Endo,N
286,5,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
286,6,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
287,1,Apraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
287,2,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
287,3,Blood bicarbonate decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
287,4,Blood immunoglobulin A increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
287,5,Blood immunoglobulin G increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
287,6,Blood immunoglobulin M increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
287,7,Blood viscosity increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
287,8,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
287,9,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
287,10,CD4 lymphocytes,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
287,11,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
287,12,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
287,13,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
287,14,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
287,15,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
287,16,Gaze palsy,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
287,17,Headache,Headaches NEC,Headaches,Nerv,N
287,18,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
287,19,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
287,20,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
287,21,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
287,22,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
287,23,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
287,24,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
287,25,Upper motor neurone lesion,Motor neurone diseases,Neuromuscular disorders,Nerv,N
287,26,Viral hepatitis carrier,Infectious disorders carrier,Ancillary infectious topics,Infec,N
287,27,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
288,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
288,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
288,3,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
288,4,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
288,5,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
288,6,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
288,7,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
288,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
288,9,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
289,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
289,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
289,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,Y
290,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
291,1,Retinitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
292,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
292,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
292,3,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
292,4,Post herpetic neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
292,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
293,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
293,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
293,3,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
293,4,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
293,5,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
293,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
293,7,Glycosuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
293,8,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
293,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
293,10,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
293,11,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
293,12,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
293,13,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
294,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
295,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
296,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
296,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
296,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
296,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
296,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
297,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
298,1,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
298,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
298,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
298,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
298,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
299,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
299,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
300,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
300,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
301,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
301,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
301,3,Blood antidiuretic hormone increased,Pituitary analyses posterior,Endocrine investigations (incl sex hormones),Inv,N
301,4,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
301,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
301,6,Myoglobin blood increased,Musculoskeletal and soft tissue tests NEC,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
301,7,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
302,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
302,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
302,3,Blood antidiuretic hormone increased,Pituitary analyses posterior,Endocrine investigations (incl sex hormones),Inv,N
302,4,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
302,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
302,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
302,7,Myoglobin blood increased,Musculoskeletal and soft tissue tests NEC,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
302,8,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
302,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
303,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
304,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
304,2,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
304,3,Placental infarction,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
304,4,Umbilical cord abnormality,Umbilical cord complications,Neonatal and perinatal conditions,Preg,N
305,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
305,2,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
305,3,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
306,1,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
307,1,Precocious puberty,Endocrine abnormalities of puberty,Endocrine disorders of gonadal function,Endo,N
308,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
308,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
308,3,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
308,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
308,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
308,6,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
308,7,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
309,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
310,1,Failure to thrive,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
310,2,HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
310,3,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
310,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
311,1,HIV test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
312,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
312,2,Oligohydramnios,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
313,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
314,1,Hepatic fibrosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
315,1,Sudden infant death syndrome,Death and sudden death,Fatal outcomes,Genrl,Y
316,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
317,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
317,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
317,3,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
317,4,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
317,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
318,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
318,2,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
318,3,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
319,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
319,2,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
319,3,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
320,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
320,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
320,3,Lactase deficiency,Sugar intolerance (excl glucose intolerance),Food intolerance syndromes,Metab,N
320,4,Mitochondrial toxicity,Cell metabolism disorders NEC,Metabolism disorders NEC,Metab,N
320,5,Portal vein thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
320,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
321,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
321,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
321,3,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
321,4,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
321,5,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
321,6,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
321,7,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
321,8,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
321,9,Blood pH abnormal,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
321,10,Blood pH decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
321,11,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
321,12,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
321,13,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
321,14,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
321,15,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
321,16,Hypoventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
321,17,Lactase deficiency,Sugar intolerance (excl glucose intolerance),Food intolerance syndromes,Metab,N
321,18,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
321,19,Mitochondrial cytopathy,Cell metabolism disorders NEC,Metabolism disorders NEC,Metab,N
321,20,Portal vein thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
321,21,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
322,1,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
323,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
323,2,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
323,3,Placental infarction,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
323,4,Umbilical cord abnormality,Umbilical cord complications,Neonatal and perinatal conditions,Preg,N
324,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
324,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
324,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
324,4,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
324,5,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
324,6,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
324,7,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
324,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
324,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
324,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
325,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
326,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
327,1,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
327,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
328,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
328,2,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
328,3,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
329,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
329,2,Blood immunoglobulin E increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
329,3,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
329,4,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
329,5,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
329,6,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
329,7,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
329,8,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
329,9,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
329,10,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
329,11,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
329,12,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
329,13,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
329,14,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
329,15,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
329,16,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
329,17,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
329,18,Myopathy,Myopathies,Muscle disorders,Musc,N
329,19,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
329,20,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
329,21,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
329,22,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
329,23,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
329,24,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
329,25,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
329,26,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
329,27,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
329,28,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
330,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
330,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
331,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
331,2,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
331,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
332,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
332,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
332,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
332,4,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
332,5,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
332,6,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
332,7,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
332,8,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
332,9,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
332,10,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
332,11,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
332,12,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
332,13,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
332,14,Headache,Headaches NEC,Headaches,Nerv,N
332,15,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
332,16,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
332,17,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
332,18,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
332,19,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
332,20,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
332,21,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
332,22,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
332,23,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
332,24,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
332,25,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
332,26,Sleep terror,Parasomnias,Sleep disorders and disturbances,Psych,N
332,27,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
332,28,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
332,29,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
332,30,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
333,1,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
333,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
333,3,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
334,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
335,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
335,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
335,3,Peritoneal fibrosis,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,N
336,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
336,2,Peritoneal fibrosis,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,N
337,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
338,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
338,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
338,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
338,4,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
339,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
339,2,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
339,3,Nodular regenerative hyperplasia,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
339,4,Oesophageal varices haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
339,5,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
339,6,Varices oesophageal,Oesophageal varices,Gastrointestinal vascular conditions,Gastr,N
340,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
340,2,Nodular regenerative hyperplasia,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
340,3,Oesophageal varices haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
341,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
342,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
342,2,Neuropsychiatric syndrome,Mental disorders due to a general medical condition NEC,Psychiatric disorders NEC,Psych,N
343,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
343,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
343,3,Blood antidiuretic hormone increased,Pituitary analyses posterior,Endocrine investigations (incl sex hormones),Inv,N
343,4,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
343,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
343,6,Muscle injury,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
343,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
343,8,Myoglobin blood increased,Musculoskeletal and soft tissue tests NEC,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
343,9,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
343,10,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
344,1,Campylobacter gastroenteritis,Campylobacter infections,Bacterial infectious disorders,Infec,N
344,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
345,1,Mitochondrial myopathy,Genetic mitochondrial abnormalities NEC,Cytoplasmic disorders congenital,Cong,N
346,1,Mitochondrial myopathy,Genetic mitochondrial abnormalities NEC,Cytoplasmic disorders congenital,Cong,N
347,1,Mitochondrial myopathy,Genetic mitochondrial abnormalities NEC,Cytoplasmic disorders congenital,Cong,N
348,1,Mitochondrial myopathy,Genetic mitochondrial abnormalities NEC,Cytoplasmic disorders congenital,Cong,N
349,1,Mitochondrial myopathy,Genetic mitochondrial abnormalities NEC,Cytoplasmic disorders congenital,Cong,N
350,1,Mitochondrial myopathy,Genetic mitochondrial abnormalities NEC,Cytoplasmic disorders congenital,Cong,N
351,1,Mitochondrial myopathy,Genetic mitochondrial abnormalities NEC,Cytoplasmic disorders congenital,Cong,N
352,1,Mitochondrial myopathy acquired,Myopathies,Muscle disorders,Musc,N
353,1,Mitochondrial myopathy acquired,Myopathies,Muscle disorders,Musc,N
354,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
354,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
355,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
355,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
355,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
356,1,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
356,2,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
356,3,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
356,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
356,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
356,6,Placental insufficiency,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
356,7,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
357,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
357,2,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
357,3,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
357,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
357,5,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
358,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
358,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
358,3,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
358,4,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
358,5,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
358,6,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
358,7,Premature rupture of membranes,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
358,8,Twin pregnancy,Multiple pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
358,9,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
359,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
359,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
359,3,Premature separation of placenta,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
360,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
360,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
360,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
360,4,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
361,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
361,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
361,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
362,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
362,2,Oligohydramnios,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
362,3,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
362,4,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
363,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
363,2,HIV test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
364,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
364,2,HELLP syndrome,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
364,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
364,4,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
364,5,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
365,1,HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
365,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
365,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
365,4,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
365,5,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
366,1,Arnold-Chiari malformation,Cerebellar disorders congenital,Neurological disorders congenital,Cong,N
366,2,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
366,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
366,4,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
366,5,Meningomyelocele,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
366,6,Spina bifida,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
367,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
367,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
367,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
367,4,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
367,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
368,1,Failure to thrive,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
368,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
368,3,HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
368,4,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
368,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
369,1,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,Y
369,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
370,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
370,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
371,1,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
371,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
372,1,Brain malformation,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
372,2,Congenital central nervous system anomaly,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
372,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
372,4,Pulmonary hypoplasia,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
373,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
373,2,Sudden infant death syndrome,Death and sudden death,Fatal outcomes,Genrl,Y
374,1,Foetal disorder,Foetal complications NEC,Foetal complications,Preg,N
374,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
375,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
375,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
375,3,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
375,4,Mitochondrial toxicity,Cell metabolism disorders NEC,Metabolism disorders NEC,Metab,N
375,5,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
375,6,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
376,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
376,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
376,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
377,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
377,2,Sudden infant death syndrome,Death and sudden death,Fatal outcomes,Genrl,Y
378,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
378,2,Gestational hypertension,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
378,3,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,Y
378,4,Mitochondrial toxicity,Cell metabolism disorders NEC,Metabolism disorders NEC,Metab,N
378,5,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
378,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
378,7,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
379,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
379,2,Insulin resistance,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
379,3,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
379,4,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
379,5,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
379,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
379,7,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
380,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
380,2,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
380,3,HELLP syndrome,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
380,4,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
380,5,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
380,6,Laryngeal oedema,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
380,7,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
380,8,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
380,9,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
380,10,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
381,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
381,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
381,3,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
381,4,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
381,5,Meconium stain,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
381,6,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
381,7,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
381,8,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
381,9,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
381,10,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
382,1,Ependymoma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
382,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
382,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
383,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
383,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,Y
383,3,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
383,4,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
384,1,Amniotic cavity infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
384,2,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
384,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
384,4,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
384,5,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
384,6,Premature rupture of membranes,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
385,1,Congenital foot malformation,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
385,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
386,1,Congenital hydronephrosis,Renal and urinary tract disorders congenital NEC,Renal and urinary tract disorders congenital,Cong,N
386,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
387,1,Congenital cardiovascular anomaly,Cardiovascular disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
387,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
388,1,Congenital small intestinal atresia,Intestinal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
388,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
389,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
389,2,Trisomy 21,Autosomal chromosomal abnormalities,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
390,1,Congenital cardiovascular anomaly,Cardiovascular disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
390,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
391,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
392,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
393,1,Congenital central nervous system anomaly,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
393,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
393,3,Pulmonary hypoplasia,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
394,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
394,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
395,1,Delayed puberty,Endocrine abnormalities of puberty,Endocrine disorders of gonadal function,Endo,N
395,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
395,3,Failure to thrive,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
395,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
396,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
396,2,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
396,3,Non-cirrhotic portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
397,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
397,2,Ovarian failure,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
398,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
398,2,Delayed puberty,Endocrine abnormalities of puberty,Endocrine disorders of gonadal function,Endo,N
398,3,Infertility,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
398,4,Ovarian failure,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
399,1,Non-cirrhotic portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
399,2,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
400,1,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
401,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
401,2,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
401,3,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
402,1,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
403,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
403,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
403,3,Headache,Headaches NEC,Headaches,Nerv,N
403,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
403,5,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
403,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
403,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
403,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
404,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
404,2,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
405,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
405,2,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
406,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
406,2,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
407,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
407,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
408,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
408,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
409,1,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
410,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
410,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
411,1,Congenital central nervous system anomaly,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
411,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
411,3,Pulmonary hypoplasia,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,Y
